LA

Leila Alland

Radiopharm Theranostics Limited | Non-Executive Director
Dr Alland is a pediatric hematologist-oncologist with a record in developing oncology drug products. She has held positions at AstraZeneca, Bristol-Myers Squibb, Novartis and Schering-Plough, where she contributed to multiple drug approvals. Dr Alland is currently Chief Medical Officer of PMV Pharmaceuticals, a clinical stage precision oncology company. During her academic tenure, she was awarded the James S McDonnell Foundation Scholar Award and pursued basic cancer research while also caring for children with cancer and blood disorders. Her Other current directorship is with Abeona Therapeutics Inc (NASDAQ: ABEO) since April 2021. She is a member of risk committee.

Company and Role

Company
Title
Tenure
Since
RAD
Radiopharm Theranostics Limited
  • Non-Executive Director
1yrs, 10mthJun 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RAD
Radiopharm Theranostics Limited
08/12/2371,740N/A1,900,002N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RAD
Radiopharm Theranostics Limited
08/12/23
Issued
71,740$0.070$5,021Rights issue
RAD
Radiopharm Theranostics Limited
05/12/22
Issued
1,900,002$0.115$218,500Issue of options